Molecular biomarkers for lung adenocarcinoma Source: Eur Respir J , 49 (4) 1601734; DOI: 10.1183/13993003.01734-2016 Year: 2017
Molecular imprint of lung cancer development Source: ERS Lung Science Conference 2017 Year: 2017
Molecular pathology and precision medicine for lung cancer Source: International Congress 2017 – Precision medicine approaches in lung cancer Year: 2017
Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features Source: Eur Respir J 2006; 28: Suppl. 50, 335s Year: 2006
Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology Source: Eur Respir Mon; 2010: 48: 272–296 Year: 2010
Latest treatable molecular alterations in lung cancer Source: International Congress 2017 – A novel approach to lung cancer Year: 2017
Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012
Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015
The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP) Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy Year: 2013
Cytological diagnostics of lung cancer: our experience Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005
Imaging and lung cancer Source: International Congress 2017 – GR1 Imaging Grand Round Year: 2017
Contribution of immunological examination to the diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 65s Year: 2001
Tissue diagnosis in lung cancer Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010
Evolution in the pathological study of lung cancer Source: Virtual Congress 2020 – Management issues in thoracic oncology Year: 2020